News on lab-developed tests and emerging diagnostic technologies.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The FDA also reissued Emergency Use Authorizations for SARS-CoV-2 tests from Roche and Express Gene to reflect their permitted use with additional sample types.
Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.
The xT platform integrates structured clinical patient data with results from a 648-gene DNA panel and whole-transcriptome RNA sequencing.
The investment bank said it expects demand for Fulgent's COVID-19 testing to decline over the next two years.
